ArticleRSC advances2020
Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid.
Meng-Meng Wang, Xu-Ling Xue, Xi-Xi Sheng, Yan Su, Ya-Qiong Kong, Yong Qian, Jian-Chun Bao, Zhi Su, Hong-Ke Liu
Open access · goldAbstract read
In one paragraphArticle in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 26 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 1 institution in 1 country.
Meng-Meng WangJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Xu-Ling XueJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Xi-Xi ShengJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Yan SuJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Ya-Qiong KongJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Yong QianJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.
Jian-Chun BaoJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.ORCID https://orcid.org/0000-0003-2818-6786 Zhi SuJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.ORCID https://orcid.org/0000-0003-1690-527X Hong-Ke LiuJiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University Nanjing 210023 China zhisu@njnu.edu.cn liuhongke@njnu.edu.cn.ORCID https://orcid.org/0000-0002-0968-6518 Nanjing Normal University · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Alpha lipoic acid (LA) is a natural compound and coenzyme with sufficient safety information for serving as a promising anticancer agent. To further clarify the mechanism of action (MoA), two Ir(iii) complexes with the functionalized α-lipoic acid (N
Identifiers
PMID35498295
PMCPMC9049077
OpenAlexW3003847669
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390